US Stock MarketDetailed Quotes
NEUE NeueHealth
- 5.000
- -0.070-1.38%
Close Nov 15 16:00 ET
41.42MMarket Cap-97P/E (TTM)
5.250High5.000Low4.18KVolume5.000Open5.070Pre Close21.09KTurnover0.12%Turnover RatioLossP/E (Static)8.28MShares16.59052wk High-0.03P/B17.06MFloat Cap4.66052wk Low--Dividend TTM3.41MShs Float1434.400Historical High--Div YieldTTM4.93%Amplitude4.660Historical Low5.049Avg Price1Lot Size
NeueHealth Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 98.70%-21.68M | 73.92%-28.43M | 92.08%-48.72M | -1,262.87%-2.73B | -369.99%-331.23M | -171.81%-1.67B | -145.06%-109M | -226.87%-615.02M | 185.73%234.47M | 181.21%122.68M |
| Net income from continuing operations | 92.62%-40.37M | 34.90%-57.7M | 97.54%-4.18M | 6.92%-1.27B | 29.98%-460.57M | -102.55%-547.15M | 64.74%-88.63M | 6.18%-169.46M | -14.77%-1.36B | 19.24%-657.79M |
| Operating gains losses | --0 | --2.42M | -240.65%-1.83M | 85.68%20.39M | ---- | ---- | ---- | --1.3M | --10.98M | ---- |
| Depreciation and amortization | -15.01%3.5M | -35.16%3.98M | -53.88%4.56M | -52.22%24.17M | -61.37%4.02M | -70.34%4.12M | -53.62%6.14M | -24.15%9.89M | 42.53%50.58M | 9.46%10.4M |
| Deferred tax | --0 | --0 | --0 | -251.11%-3.06M | --0 | -1,002.75%-3.94M | 0.00%437K | -39.19%436K | 107.90%2.03M | 105.67%437K |
| Other non cash items | 16,379.75%12.86M | -113.79%-471K | -6,480.84%-30.31M | -82.52%1.86M | -145.93%-1.95M | -101.74%-79K | 727.94%3.42M | -80.03%475K | -47.51%10.63M | -25.36%4.25M |
| Change In working capital | 98.93%-16.39M | 80.67%-6.82M | 92.69%-35.56M | -285.98%-2.16B | -114.81%-97.3M | -203.62%-1.54B | -107.99%-35.25M | -185.54%-486.4M | -7.10%1.16B | 9.15%657.07M |
| -Change in receivables | -33.68%158.78M | -29.74%217.09M | 35.73%-531.6M | 65.26%-24.45M | 65.71%254.28M | 17.55%239.41M | 28.55%308.97M | -23.84%-827.11M | -113.70%-70.39M | 1,176.22%153.45M |
| -Change in payables and accrued expense | 99.05%-15.21M | 81.12%-24.44M | 94.41%-30.1M | -278.67%-2.31B | -104.80%-37.85M | -137.35%-1.61B | -129.40%-129.46M | -172.44%-538.72M | -8.17%1.29B | 20.46%788.41M |
| -Change in other current assets | -95.54%3.33M | -112.38%-4.38M | -115.62%-3.51M | 976.88%191.44M | 5.52%58.8M | 551.68%74.8M | 191.42%35.4M | 200.80%22.45M | 84.78%-21.83M | 198.40%55.72M |
| -Change in other current liabilities | 31.94%-163.28M | 20.28%-195.08M | -26.38%529.66M | ---- | ---- | -54.33%-239.92M | -9.77%-244.72M | 34.84%719.42M | ---- | ---- |
| -Change in other working capital | 99.86%-7K | --0 | -100.01%-11K | 75.18%-10.61M | 25.68%-137.75M | -103.59%-4.99M | -124.72%-5.43M | 847.54%137.56M | -386.94%-42.76M | -1,108.58%-185.36M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 98.70%-21.68M | 73.92%-28.43M | 92.08%-48.72M | -1,262.87%-2.73B | -369.99%-331.23M | -171.81%-1.67B | -145.06%-109M | -226.87%-615.02M | 185.73%234.47M | 181.21%122.68M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.01%-51K | 98.28%-9.11M | -71.11%198.39M | 360.55%1.12B | -177.21%-25.81M | 102.34%988.31M | -66.32%-529.66M | 208.48%686.79M | 22.28%-429.72M | -66.65%33.43M |
| Net PPE purchase and sale | -186.64%-665K | -53.11%-813K | 96.56%-64K | 89.45%-2.9M | 95.38%-271K | 96.39%-232K | 94.50%-531K | 66.07%-1.86M | 9.75%-27.45M | 39.69%-5.87M |
| Net business purchase and sale | --0 | 148.29%991K | 14,216.06%196.13M | -120.00%-682K | --0 | --0 | ---2.05M | 541.94%1.37M | 99.93%-310K | --0 |
| Net investment purchase and sale | -99.94%614K | 98.24%-9.28M | -99.66%2.32M | 379.43%1.12B | -164.99%-25.54M | 99.76%988.55M | -70.69%-527.08M | 209.56%687.28M | -343.24%-401.97M | -64.29%39.3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.01%-51K | 98.28%-9.11M | -71.11%198.39M | 360.55%1.12B | -177.21%-25.81M | 102.34%988.31M | -66.32%-529.66M | 208.48%686.79M | 22.28%-429.72M | -66.65%33.43M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -128.98%-13.32M | 1,675.49%49.57M | -15,172.73%-275.52M | -95.32%49.91M | -94.78%8.9M | -84.91%45.96M | -112.71%-3.15M | -100.30%-1.8M | 2.18%1.07B | 9.53%170.66M |
| Net issuance payments of debt | -120.56%-10.28M | --52.41M | ---273.64M | -55.42%66.4M | --16.4M | -83.55%50M | --0 | --0 | -3.91%148.95M | --0 |
| Net common stock issuance | --0 | --0 | --0 | --0 | -300.00%-2K | --0 | -99.76%1K | -99.61%1K | -99.85%1.32M | -99.88%1K |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --920.42M | --172.94M |
| Net other financing activities | 24.82%-3.04M | 9.56%-2.85M | -4.38%-1.88M | -282.60%-16.49M | -228.96%-7.5M | -2,831.16%-4.05M | ---3.15M | ---1.81M | 57.22%-4.31M | ---2.28M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -128.98%-13.32M | 1,675.49%49.57M | -15,172.73%-275.52M | -95.32%49.91M | -94.78%8.9M | -84.91%45.96M | -112.71%-3.15M | -100.30%-1.8M | 2.18%1.07B | 9.53%170.66M |
| Net cash flow | ||||||||||
| Beginning cash position | -80.78%261.46M | -87.54%249.43M | -80.58%375.28M | 82.09%1.93B | -54.94%723.42M | -4.70%1.36B | 32.99%2B | 82.09%1.93B | 117.29%1.06B | 67.91%1.61B |
| Current changes in cash | 94.50%-35.05M | 101.87%12.03M | -279.89%-125.85M | -278.74%-1.56B | -206.54%-348.14M | -457.86%-637.02M | -722.52%-641.81M | -84.26%69.96M | 52.08%871.11M | 211.23%326.77M |
| End cash Position | -68.70%226.41M | -80.78%261.46M | -87.54%249.43M | -80.58%375.28M | -80.58%375.28M | -54.94%723.42M | -4.70%1.36B | 32.99%2B | 82.09%1.93B | 82.09%1.93B |
| Free cash flow | 98.66%-22.34M | 73.30%-29.24M | 92.09%-48.78M | -1,418.46%-2.73B | -383.79%-331.5M | -169.04%-1.67B | -147.16%-109.53M | -228.71%-616.89M | 300.85%207.02M | 172.65%116.81M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data